211 related articles for article (PubMed ID: 22972920)
1. B7x in the periphery abrogates pancreas-specific damage mediated by self-reactive CD8 T cells.
Lee JS; Scandiuzzi L; Ray A; Wei J; Hofmeyer KA; Abadi YM; Loke P; Lin J; Yuan J; Serreze DV; Allison JP; Zang X
J Immunol; 2012 Oct; 189(8):4165-74. PubMed ID: 22972920
[TBL] [Abstract][Full Text] [Related]
2. Tissue-specific expression of B7x protects from CD4 T cell-mediated autoimmunity.
Wei J; Loke P; Zang X; Allison JP
J Exp Med; 2011 Aug; 208(8):1683-94. PubMed ID: 21727190
[TBL] [Abstract][Full Text] [Related]
3. Tissue-expressed B7x affects the immune response to and outcome of lethal pulmonary infection.
Hofmeyer KA; Scandiuzzi L; Ghosh K; Pirofski LA; Zang X
J Immunol; 2012 Sep; 189(6):3054-63. PubMed ID: 22855708
[TBL] [Abstract][Full Text] [Related]
4. B7x/B7-H4 modulates the adaptive immune response and ameliorates renal injury in antibody-mediated nephritis.
Pawar RD; Goilav B; Xia Y; Herlitz L; Doerner J; Chalmers S; Ghosh K; Zang X; Putterman C
Clin Exp Immunol; 2015 Feb; 179(2):329-43. PubMed ID: 25205493
[TBL] [Abstract][Full Text] [Related]
5. Host b7x promotes pulmonary metastasis of breast cancer.
Abadi YM; Jeon H; Ohaegbulam KC; Scandiuzzi L; Ghosh K; Hofmeyer KA; Lee JS; Ray A; Gravekamp C; Zang X
J Immunol; 2013 Apr; 190(7):3806-14. PubMed ID: 23455497
[TBL] [Abstract][Full Text] [Related]
6. Co-inhibitory Molecule B7 Superfamily Member 1 Expressed by Tumor-Infiltrating Myeloid Cells Induces Dysfunction of Anti-tumor CD8
Li J; Lee Y; Li Y; Jiang Y; Lu H; Zang W; Zhao X; Liu L; Chen Y; Tan H; Yang Z; Zhang MQ; Mak TW; Ni L; Dong C
Immunity; 2018 Apr; 48(4):773-786.e5. PubMed ID: 29625896
[TBL] [Abstract][Full Text] [Related]
7. Low dose streptozotocin-induced diabetes in rat insulin promoter-mCD80-transgenic mice is T cell autoantigen-specific and CD28 dependent.
Pechhold K; Patterson NB; Blum C; Fleischacker CL; Boehm BO; Harlan DM
J Immunol; 2001 Feb; 166(4):2531-9. PubMed ID: 11160314
[TBL] [Abstract][Full Text] [Related]
8. PD-1 regulates self-reactive CD8+ T cell responses to antigen in lymph nodes and tissues.
Keir ME; Freeman GJ; Sharpe AH
J Immunol; 2007 Oct; 179(8):5064-70. PubMed ID: 17911591
[TBL] [Abstract][Full Text] [Related]
9. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
10. Synergistic effects of host B7-H4 deficiency and gemcitabine treatment on tumor regression and anti-tumor T cell immunity in a mouse model.
Leung J; St-Onge P; Stagg J; Suh WK
Cancer Immunol Immunother; 2017 Apr; 66(4):491-502. PubMed ID: 28074226
[TBL] [Abstract][Full Text] [Related]
11. B7 immune-checkpoints as targets for the treatment of neuroendocrine tumors.
Yuan Z; Gardiner JC; Maggi EC; Huang S; Adem A; Bagdasarov S; Li G; Lee S; Slegowski D; Exarchakis A; Howe JR; Lattime EC; Zang X; Libutti SK
Endocr Relat Cancer; 2021 Feb; 28(2):135-149. PubMed ID: 33410766
[TBL] [Abstract][Full Text] [Related]
12. CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.
Martinez X; Kreuwel HT; Redmond WL; Trenney R; Hunter K; Rosen H; Sarvetnick N; Wicker LS; Sherman LA
J Immunol; 2005 Aug; 175(3):1677-85. PubMed ID: 16034108
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cytokine-driven functional differentiation of CD8 T cells by suppressor of cytokine signaling 1 controls autoimmunity and preserves their proliferative capacity toward foreign antigens.
Ramanathan S; Dubois S; Gagnon J; Leblanc C; Mariathasan S; Ferbeyre G; Rottapel R; Ohashi PS; Ilangumaran S
J Immunol; 2010 Jul; 185(1):357-66. PubMed ID: 20519645
[TBL] [Abstract][Full Text] [Related]
14. The diabetogenic, insulin-specific CD8 T cell response primed in the experimental autoimmune diabetes model in RIP-B7.1 mice.
Karges W; Rajasalu T; Spyrantis A; Wieland A; Boehm B; Schirmbeck R
Eur J Immunol; 2007 Aug; 37(8):2097-103. PubMed ID: 17615584
[TBL] [Abstract][Full Text] [Related]
15. Systemic administration of agonist peptide blocks the progression of spontaneous CD8-mediated autoimmune diabetes in transgenic mice without bystander damage.
Bercovici N; Heurtier A; Vizler C; Pardigon N; Cambouris C; Desreumaux P; Liblau R
J Immunol; 2000 Jul; 165(1):202-10. PubMed ID: 10861053
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.
Tong Z; Liu W; Yan H; Dong C
Immunology; 2015 Oct; 146(2):339-46. PubMed ID: 26211676
[TBL] [Abstract][Full Text] [Related]
17. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
18. B1 cells promote pancreas infiltration by autoreactive T cells.
Ryan GA; Wang CJ; Chamberlain JL; Attridge K; Schmidt EM; Kenefeck R; Clough LE; Dunussi-Joannopoulos K; Toellner KM; Walker LS
J Immunol; 2010 Sep; 185(5):2800-7. PubMed ID: 20675587
[TBL] [Abstract][Full Text] [Related]
19. Deficiency in B7-H1 (PD-L1)/PD-1 coinhibition triggers pancreatic beta-cell destruction by insulin-specific, murine CD8 T-cells.
Rajasalu T; Brosi H; Schuster C; Spyrantis A; Boehm BO; Chen L; Reimann J; Schirmbeck R
Diabetes; 2010 Aug; 59(8):1966-73. PubMed ID: 20484136
[TBL] [Abstract][Full Text] [Related]
20. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
